DrugPatentWatch Database Preview
Investigational Drug Information for Icaritin
Email this page to a colleague
What is the drug development status for Icaritin?
Icaritin is an investigational drug.
There have been 4 clinical trials for Icaritin.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2013.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, Hepatocellular, and Carcinoma. The leading clinical trial sponsors are Beijing Shenogen Biomedical Co., Ltd, Chinese Academy of Medical Sciences, and National University Hospital, Singapore.
There are thirteen US patents protecting this investigational drug and eighty-four international patents.
Summary for Icaritin
| US Patents | 13 |
| International Patents | 84 |
| US Patent Applications | 58 |
| WIPO Patent Applications | 50 |
| Japanese Patent Applications | 16 |
| Clinical Trial Progress | Phase 2 (2013-10-01) |
| Vendors | 60 |
Recent Clinical Trials for Icaritin
| Title | Sponsor | Phase |
|---|---|---|
| Epimedium Prenylflavonoid (EP) Extract for Osteoporosis and Cardiovascular Disease | National University Hospital, Singapore | Phase 1 |
| The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma | 307 Hospital of PLA | Phase 2 |
| The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma | Chinese Academy of Medical Sciences | Phase 2 |
Clinical Trial Summary for Icaritin
Top disease conditions for Icaritin
Top clinical trial sponsors for Icaritin
US Patents for Icaritin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Icaritin | ⤷ Try it Free | Gene fusions and gene variants associated with cancer | LIFE TECHNOLOGIES CORPORATION (Carlsbad, CA) | ⤷ Try it Free |
| Icaritin | ⤷ Try it Free | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try it Free |
| Icaritin | ⤷ Try it Free | Antibodies and methods for treating estrogen receptor-associated diseases | BEIJING SHENOGEN PHARMA GROUP LTD. (Beijing, CN) | ⤷ Try it Free |
| Icaritin | ⤷ Try it Free | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | ⤷ Try it Free |
| Icaritin | ⤷ Try it Free | Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers | ⤷ Try it Free | |
| Icaritin | ⤷ Try it Free | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | Lunan Pharmaceutical Group Corporation (Linyi, CN) | ⤷ Try it Free |
| Icaritin | ⤷ Try it Free | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | LUNAN PHARMACEUTICAL GROUP CORPORATION (Linyi, CN) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Icaritin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Icaritin | Australia | AU2014254394 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | China | CN105378110 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | China | CN106414768 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | European Patent Office | EP2986736 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | European Patent Office | EP3122901 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | European Patent Office | EP3438288 | 2033-04-17 | ⤷ Try it Free |
| Icaritin | Japan | JP2016518123 | 2033-04-17 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
